Benzinga.com

Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy

On Thursday, the FDA approved Elanco Animal Health Incorporated’s (NYSE:ELAN) Zenrelia, a once-daily oral JAK inhibitor for the control of pruritus (itching) associated with allergic dermatitis and ...
Yahoo Finance

Meet the Faces of Zen: Elanco's Zenrelia(TM) (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Nasdaq

Elanco Gets FDA Nod For Updated Zenrelia Label, Removes Vaccine-Induced Disease Warning

(RTTNews) - Elanco Animal Health Incorporated (ELAN) on Tuesday said that the U.S. Food and Drug Administration (FDA) has approved an updated label for its Zenrelia, removing language related to ...
Hosted on MSN

Elanco gets FDA nod to remove vaccine risk warning from Zenrelia label

Elanco Animal Health (NYSE:ELAN) on Tuesday reported key updates to the U.S. label for Zenrelia, after the FDA reviewed additional scientific data, sending shares up 1.1% in premarket trading. The ...
Hosted on MSN

Elanco gains positive EMA opinion for Zenrelia for itching in dogs

The European Medicines Agency's Committee for Veterinary Medicinal Products has issued a positive opinion for Elanco Animal Health's (NYSE:ELAN) Zenrelia (ilunocitinib) for the treatment of pruritus ...
Nasdaq

Elanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology

GREENFIELD, Ind., Sept. 19, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved Zenrelia™, a safe, highly ...